Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Zejula“
Suchtreffer
Begriffe & Kennungen
Zejula · 4.8 · 31 System organ class Frequency of all CTCAE Frequency of CTCAE grades grade 3 or 4 Gastrointestinal disorders
Eintrag öffnenZejula · 4.8 · 32 and 2% of patients, respectively.
Eintrag öffnenZejula · 4.8 · 33 Myelodysplastic syndrome/Acute myeloid leukaemia In clinical studies, MDS/AML occurred in 1% patients treat
Eintrag öffnenZejula · 4.8 · 8 Frequencies of occurrence of undesirable effects are based on pooled adverse events data generated from the
Eintrag öffnenZejula · 4.8 · 9 System organ class Frequency of all CTCAE Frequency of CTCAE grades grade 3 or 4 Vascular disorders Very com
Eintrag öffnenZejula · 4.8 · Adverse reactions of all grades occurring in ≥10% of the 851 patients receiving Zejula monotherapy in the pool
Eintrag öffnenZejula · 4.8 · Adverse reactions of all grades occurring in ≥10% of the 851 patients receiving Zejula monotherapy in the pool
Eintrag öffnenZejula · 4.8 · Anaemia In PRIMA, 31% of Zejula-treated patients experienced Grade 3/4 anaemia compared to 2% of placebo-treat
Eintrag öffnenZejula · 4.8 · Anaemia In PRIMA, 31% of Zejula-treated patients experienced Grade 3/4 anaemia compared to 2% of placebo-treat
Eintrag öffnenZejula · 4.8 · Description of selected adverse reactions
Eintrag öffnenZejula · 4.8 · Description of selected adverse reactions
Eintrag öffnenZejula · 4.8 · Frequencies of occurrence of undesirable effects are based on pooled adverse events data generated from the PR
Eintrag öffnenZejula · 4.8 · Haematologic adverse reactions (thrombocytopenia, anaemia, neutropenia) including clinical diagnoses and/or la
Eintrag öffnenZejula · 4.8 · Haematologic adverse reactions (thrombocytopenia, anaemia, neutropenia) including clinical diagnoses and/or la
Eintrag öffnenZejula · 4.8 · Hypertension In PRIMA, Grade 3/4 hypertension occurred in 6% of Zejula-treated patients compared to 1% of plac
Eintrag öffnenZejula · 4.8 · Hypertension In PRIMA, Grade 3/4 hypertension occurred in 6% of Zejula-treated patients compared to 1% of plac
Eintrag öffnenZejula · 4.8 · In NOVA and PRIMA, patients eligible for Zejula therapy had the following baseline haematologic parameters: ab
Eintrag öffnenZejula · 4.8 · In NOVA, 13% (48/367) of patients experienced bleeding with concurrent thrombocytopenia; all bleeding events c
Eintrag öffnenZejula · 4.8 · In NOVA, 13% (48/367) of patients experienced bleeding with concurrent thrombocytopenia; all bleeding events c
Eintrag öffnenZejula · 4.8 · In NOVA, approximately 30% of patients experienced neutropenia of any grade, and 20% of patients experienced G
Eintrag öffnen